International Vaccine Institute
Clinical trials sponsored by International Vaccine Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cholera vaccine trial aims to protect south africans of all ages Results expected Dec 2026 (estimated)
- Could a malaria vaccine ward off another deadly disease? Results expected Feb 2027 (estimated)
- New cholera vaccine trial aims to protect families in High-Risk areas Results expected Mar 2027 (estimated)
- New cholera pill tested in sweden – first human study begins Results expected Jul 2027 (estimated)
- Massive mpox vaccine trial launches in DRC: could it stop the outbreak? Results expected Aug 2027 (estimated)
-
New vaccine aims to stop deadly diarrhea in kids
Vaccine Not yet recruitingThis study tests a new vaccine (IP-QSV) designed to protect against four types of Shigella bacteria, which cause severe diarrhea. The trial will include 370 healthy adults, children, and infants in Mali. Researchers will check if the vaccine is safe and triggers a strong immune r…
Phase 1/2 • Sponsor: International Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 14:02 UTC
-
New cholera pill tested in sweden – first human study begins
Vaccine Not yet recruitingThis early-stage study tests a new oral cholera vaccine called DuoChol in 60 healthy adults aged 18 to 45 in Sweden. Participants will receive two doses of either DuoChol or an existing vaccine (Dukoral) to compare safety and immune response. The goal is to gather initial data to…
Phase 1 • Sponsor: International Vaccine Institute • Aim: Vaccine
Last updated Jun 27, 2026 12:02 UTC